NASH drugs race to cross finish line – Pharmaceutical Technology
Isometric illustration of a liver test. NASH is a condition caused by liver dysfunction. Credit: Mono via Getty Images Following a negative decision by the US Food and Drug Administration (FDA) for Intercept Pharmaceuticals Ocaliva (obeticholic acid), all eyes are now on the next possible drug to lead the race to market for nonalcoholic steatohepatitis … Read more